Acute Myeloid Leukemia Market Size to Surpass US$ 4.31

Pune, Oct. 19, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global acute myeloid leukemia market is expected to clock US$ 4.31 billion by 2030 and to grow at a CAGR of 10.2% during the forecast period.  This exclusive information is published by Growth Plus Reports in its report titled “Acute Myeloid Leukemia Market – Global Outlook & Forecast 2022-2030”

Market Drivers

The primary driving force behind the growth of the global acute myeloid leukemia market is the rising incidence rate of the disease and the rising death rate among patients worldwide. In addition, the patient pool for acute myeloid leukemia is rising as the geriatric population grows. The discovery of new drugs is being aided by the increased progress in pharmacology and molecular biology, fueling the global market expansion. Furthermore, the government and non-governmental organizations are raising awareness about early cancer detection and treatment, increasing the demand for acute myeloid leukemia treatment. Similarly, advances in research into targeted therapies and biologics are playing an essential role in expanding the global acute myeloid leukemia market. The rise in unhealthy lifestyle choices, such as tobacco use and alcohol consumption, also expands the patient pool for acute myeloid leukemia. The global acute myeloid leukemia market is also anticipated to grow due to increased expenditure in research & development, as more clinical trials are being done to show the effectiveness of the treatments.

The global acute myeloid leukemia market has been analyzed from four perspectives – drug class, and region.

Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/acute-myeloid-leukemia-market/7913

Excerpts from ‘By Drug Class Segmentation’

Based on material types, the global acute myeloid leukemia market is divided into:

• Antineoplastics
• Kinase Inhibitors
• Hedgehog Pathway…